Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Mol Biochem Parasitol. 2010 Dec 30;176(2):98–108. doi: 10.1016/j.molbiopara.2010.12.009

Fig. 4.

Fig. 4

Crystal structure of LmajGSK-3 short modeled with the CDK1/2 Inhibitor III. The α-helical and β-strand domains are colored cyan and blue, respectively. The hinge and activation loop of the active site are highlighted in yellow. The glycine-rich loop that is disordered in the crystal structure is depicted as magenta dots. The CDK1/2 Inhibitor III is absent from the crystal structure, but drawn here to depict the location of the inhibitor-binding site.